Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026)
Caring Brands (CABR) recorded quarterly Net Income towards Common Stockholders of -$3.9 million in Q1 2026, down 3.13% quarter-over-quarter from -$3.7 million in Q4 2025, and down 615.16% on a YoY basis from $747934.9 in Q1 2025.
Caring Brands (CABR) Net Income towards Common Stockholders (2024 - 2026) Analysis & Trends
Caring Brands' Net Income towards Common Stockholders history runs 3 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders fell 615.16% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at -$9.1 million (changed N/A YoY), while the FY2025 annual figure was -$6.0 million, changed N/A from the prior year.
- Net Income towards Common Stockholders was -$3.9 million for Q1 2026 at Caring Brands, down from -$3.7 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of -$428906.0 in Q3 2024 to a low of -$3.9 million in Q1 2026.
- Historically, Net Income towards Common Stockholders has averaged -$1.7 million across 3 years, with a median of -$940779.5 in 2024.
- The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders plunged 137.53% in 2025, then tumbled 615.16% in 2026.
- A 3-year view of Net Income towards Common Stockholders shows it stood at -$862791.0 in 2024, then plunged by 333.02% to -$3.7 million in 2025, then declined by 3.13% to -$3.9 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$3.9 million (Q1 2026), -$3.7 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 366.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 1.99 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Caring Brands | 16.18 Mn | 17.94 Mn | - | -3.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.85 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -1.02 Mn |
| Mar 31, 2025 | -538,770.00 |
| Dec 31, 2024 | -862,791.00 |
| Sep 30, 2024 | -428,906.00 |